1.
End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography
by Ardila, Diego
Nature medicine, 2019-06, Vol.25 (6), p.954-961
2.
Screening for gastric cancer in Asia: current evidence and practice
by Leung, Wai K, Dr
The lancet oncology, 2008, Vol.9 (3), p.279-287
3.
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Eff...
by Mulder, Renée L, Dr
The lancet oncology, 2013, Vol.14 (13), p.e621-e629
4.
Reliability and Validity of the Chinese Version of Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F)
by Guo, Cuihua
Journal of autism and developmental disorders, 2018-07-25, Vol.49 (1), p.185-196
5.
The benefits and harms of breast cancer screening: an independent review
by Independent UK Panel on Breast Cancer Screening
The Lancet (British edition), 2012, Vol.380 (9855), p.1778-1786
6.
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
by Field, J K
Thorax, 2016-02, Vol.71 (2), p.161-170
7.
To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in...
by Menvielle, Gwenn
Cancer causes & control, 2014-08-01, Vol.25 (8), p.977-983
8.
HPV vaccination crisis in Japan
by Hanley, Sharon J B
The Lancet (British edition), 2015, Vol.385 (9987), p.2571-2571
9.
Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six...
by Gallagher, Paul
Age and ageing, 2009-09, Vol.38 (5), p.603-606
10.
Cost-effectiveness of Colorectal Cancer Screening
by Lansdorp - Vogelaar, Iris
Epidemiologic reviews, 2011, Vol.33 (1), p.88-100
11.
Reconsidering the Criteria for Evaluating Proposed Screening Programs: Reflections From 4 Current and Former Members of the U.S. Preventive Services Task Force
by Harris, Russell
Epidemiologic reviews, 2011, Vol.33 (1), p.20-35
12.
Haemochromatosis
by Powell, Lawrie W, Prof
The Lancet (British edition), 2016, Vol.388 (10045), p.706-716
13.
Balancing the benefits and risks of choice
by Lancet, The
The Lancet (British edition), 2016, Vol.388 (10050), p.1129-1129
14.
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
by Shields, B. M
Diabetologia, 2010-05-25, Vol.53 (12), p.2504-2508
15.
ANA screening: an old test with new recommendations
by Meroni, Pier Luigi
Annals of the Rheumatic Diseases, 2010-08, Vol.69 (8), p.1420-1422
16.
CT screening for lung cancer: countdown to implementation
by Field, John K, Prof
The lancet oncology, 2013, Vol.14 (13), p.e591-e600
17.
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study
by Heuvelmans, Marjolein A
Lung cancer (Amsterdam, Netherlands), 2017-11, Vol.113, p.45-50
18.
Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
by Gelder, Rianne
Epidemiologic reviews, 2011, Vol.33 (1), p.111-121
19.
20.
Screening of colorectal cancer: present and future
by Maida, Marcello
Expert review of anticancer therapy, 2017-12-02, Vol.17 (12), p.1131-1146
